Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Effects of Magnesium Supplementation on Vascular Structure and Function in Hypertensive Patients [Phase 4]
Phase 4 trial evaluating whether magnesium supplementation improves vascular structure and endothelial function in hypertensive patients. Th…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic study of a Livalo fixed-dose combination containing pitavastatin in healthy subjects; the trial has completed.
-
CLINICAL_TRIALS research · 2013-01-01Clinical Trial Update: Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment
A clinical trial update examining the economic impact of switching from metoprolol to nebivolol for treating hypertension.
-
CLINICAL_TRIALS trial_result · 2012-12-28Clinical Trial Update: Cardiorespiratory Performance in Diabetic Elderly [NA]
A completed clinical trial evaluating cardiorespiratory performance in elderly patients with diabetes, including those with hypertension.
-
CLINICAL_TRIALS trial_result · 2012-12-24Clinical Trial Update: Do Home Monitors Improve Blood Pressure Control? [NA]
This clinical trial update notes the termination of a study evaluating whether home blood pressure monitoring improves blood pressure contro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-12-21FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic Losartan Potassium product by Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Home-Based Program to Treat High Blood Pressure in African Americans [NA]
Update on a completed clinical trial evaluating a home-based program to manage hypertension in African American participants.
-
FDA approval · 2012-12-20FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Losartan Potassium from Aurobindo Pharma Limited, resulting in approval of a generic losartan po…
-
FDA approval · 2012-12-19FDA Approved: BYSTOLIC — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for BYSTOLIC (nebivolol hydrochloride) filed by Allergan, Inc.
-
FDA approval · 2012-12-19FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for Losartan Potassium submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2012-12-19FDA Approved: LOSARTAN POTASSIUM 25 MG — Supplemental Application (Strides Pharma Science Limited)
FDA approved the supplemental application for Losartan Potassium 25 mg by Strides Pharma Science Limited, authorizing the generic product fo…
-
FDA approval · 2012-12-19FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA has approved Lupin Pharmaceuticals' supplemental application for Losartan Potassium, a generic product, via ANDA indicating an additiona…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases [Phase 2]
Phase 2 trial evaluating the safety and efficacy of Xenical (orlistat) in children and adolescents with obesity-related diseases; results we…
-
FDA approval · 2012-12-17FDA Approved: QUINAPRIL — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for Quinapril from Cipla USA Inc., marking an additional regulatory action for this ACE inhibito…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Effects of Behavioral Stress Reduction Programs on Blood Pressure in African American Youth [NA]
This update summarizes the results of a completed clinical trial evaluating whether behavioral stress reduction programs can reduce blood pr…
-
FDA approval · 2012-12-14FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic valsartan/hydrochlorothiazide fixed-dose combination from Mylan Pharmaceuticals, e…
-
CLINICAL_TRIALS trial_result · 2012-12-12Clinical Trial Update: Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study) [Phase 4]
Phase 4 trial evaluating whether adding valsartan affects morbidity and mortality in patients with hypertension and ischemic heart disease; …
-
FDA approval · 2012-12-11FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZOR, the brand-name combination of amlodipine besylate and olmesartan medoxomil, by Cosette Pha…
-
FDA approval · 2012-12-11FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide) submitted by Cosette Pharmaceuticals, Inc…
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Clinical Decision Support for Medication Management and Adherence [NA]
A clinical trial evaluating clinical decision support for medication management and adherence has completed.
-
FDA approval · 2012-12-10FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved Cosette Pharmaceuticals, Inc.'s supplemental application for Tribenzor, a fixed-dose combination of olmesartan medoxomil, amlod…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Health Effects of Recreational Soccer in Type 2 Diabetic Men [NA]
A completed clinical trial evaluating the health effects of recreational soccer in men with type 2 diabetes, examining metabolic and cardiov…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition [Phase 1]
Phase 1 bioequivalence study of Bisoprolol Fumarate 10 mg tablets under fed conditions has been completed. The study assesses bioequivalence…
-
FDA approval · 2012-12-07FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s generic diltiazem hydrochloride (ANDA 202463). The product is indicated for the management of hypertensi…
-
FDA approval · 2012-12-07FDA Approved: HYDRALAZINE HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
FDA approved a generic hydralazine hydrochloride product under Original Application ANDA200737 from Ascend Laboratories, LLC.